These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 33173650)

  • 21. Hydrogen: A Potential New Adjuvant Therapy for COVID-19 Patients.
    Yang F; Yue R; Luo X; Liu R; Huang X
    Front Pharmacol; 2020; 11():543718. PubMed ID: 33178011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Acetylcysteine to Combat COVID-19: An Evidence Review.
    Shi Z; Puyo CA
    Ther Clin Risk Manag; 2020; 16():1047-1055. PubMed ID: 33177829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Camostat mesylate against SARS-CoV-2 and COVID-19-Rationale, dosing and safety.
    Breining P; Frølund AL; Højen JF; Gunst JD; Staerke NB; Saedder E; Cases-Thomas M; Little P; Nielsen LP; Søgaard OS; Kjolby M
    Basic Clin Pharmacol Toxicol; 2021 Feb; 128(2):204-212. PubMed ID: 33176395
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and pathological findings of SARS-CoV-2 infection and concurrent IgA nephropathy: a case report.
    Huang Y; Li XJ; Li YQ; Dai W; Shao T; Liu WY; Han M; Xu G; Liu L
    BMC Nephrol; 2020 Nov; 21(1):504. PubMed ID: 33234164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cordycepin: a bioactive metabolite of C
    Verma AK
    J Biomol Struct Dyn; 2022 May; 40(8):3745-3752. PubMed ID: 33225826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Culinary spice bioactives as potential therapeutics against SARS-CoV-2: Computational investigation.
    Natesh J; Mondal P; Penta D; Abdul Salam AA; Meeran SM
    Comput Biol Med; 2021 Jan; 128():104102. PubMed ID: 33190011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug repurposing: new strategies for addressing COVID-19 outbreak.
    Shende P; Khanolkar B; Gaud RS
    Expert Rev Anti Infect Ther; 2021 Jun; 19(6):689-706. PubMed ID: 33183102
    [No Abstract]   [Full Text] [Related]  

  • 28. In Vitro Studies of Xylitol and Erythritol Inhibition of Streptococcus Mutans and Streptococcus Sobrinus Growth and Biofilm Production.
    Cannon ML; Merchant M; Kabat W; Catherine L; White K; Unruh B; Ramones A
    J Clin Pediatr Dent; 2020 Sep; 44(5):307-314. PubMed ID: 33181842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In silico analysis of selected alkaloids against main protease (M
    Garg S; Roy A
    Chem Biol Interact; 2020 Dec; 332():109309. PubMed ID: 33181114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Repurposing therapeutics for COVID-19: Rapid prediction of commercially available drugs through machine learning and docking.
    Mohapatra S; Nath P; Chatterjee M; Das N; Kalita D; Roy P; Satapathi S
    PLoS One; 2020; 15(11):e0241543. PubMed ID: 33180803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhalable Hydroxychloroquine Powders for Potential Treatment of COVID-19.
    Albariqi AH; Chang RYK; Tai W; Ke WR; Chow MYT; Tang P; Kwok PCL; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2021 Feb; 34(1):20-31. PubMed ID: 33179983
    [No Abstract]   [Full Text] [Related]  

  • 32. Favipiravir and COVID-19: A Simplified Summary.
    Ghasemnejad-Berenji M; Pashapour S
    Drug Res (Stuttg); 2021 Mar; 71(3):166-170. PubMed ID: 33176367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Grapefruit Seed Extract as a Natural Derived Antibacterial Substance against Multidrug-Resistant Bacteria.
    Han HW; Kwak JH; Jang TS; Knowles JC; Kim HW; Lee HH; Lee JH
    Antibiotics (Basel); 2021 Jan; 10(1):. PubMed ID: 33477436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smell recovery in patients with COVID-19: an experience with nebulized nasal treatment.
    Varricchio A; La Mantia I; Brunese FP; Ciprandi G
    J Biol Regul Homeost Agents; 2021; 35(2):683-686. PubMed ID: 33728831
    [No Abstract]   [Full Text] [Related]  

  • 35. Novaferon, treatment in COVID-19 patients.
    Janapala RN; Patel J; Belfaqeeh O; Alhashmi A; Pourmand A
    Int J Infect Dis; 2021 Feb; 103():297. PubMed ID: 33248244
    [No Abstract]   [Full Text] [Related]  

  • 36. Do Zinc Supplements Enhance the Clinical Efficacy of Hydroxychloroquine?: a Randomized, Multicenter Trial.
    Abd-Elsalam S; Soliman S; Esmail ES; Khalaf M; Mostafa EF; Medhat MA; Ahmed OA; El Ghafar MSA; Alboraie M; Hassany SM
    Biol Trace Elem Res; 2021 Oct; 199(10):3642-3646. PubMed ID: 33247380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled route and anti-inflammatory action of ivermectin: Do they hold promise in fighting against COVID-19?
    Mittal N; Mittal R
    Med Hypotheses; 2021 Jan; 146():110364. PubMed ID: 33246694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exploring nature's bounty: identification of
    Srivastava A; Siddiqui S; Ahmad R; Mehrotra S; Ahmad B; Srivastava AN
    J Biomol Struct Dyn; 2022 Mar; 40(4):1858-1908. PubMed ID: 33246398
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recommendations for treatment of critically ill patients with COVID-19 : Version 3 S1 guideline.
    Kluge S; Janssens U; Welte T; Weber-Carstens S; Schälte G; Salzberger B; Gastmeier P; Langer F; Welper M; Westhoff M; Pfeifer M; Hoffmann F; Böttiger BW; Marx G; Karagiannidis C
    Anaesthesist; 2021 Dec; 70(Suppl 1):19-29. PubMed ID: 33245382
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocilizumab and COVID-19: a meta-analysis of 2120 patients with severe disease and implications for clinical trial methodologies.
    Sarfraz A; Sarfraz Z; Sarfraz M; Aftab H; Pervaiz Z
    Turk J Med Sci; 2021 Jun; 51(3):890-897. PubMed ID: 33244947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.